For Immediate Assistance Call 1-800-966-2244
Mesothelioma Asbestos Mesothelioma Resources Mesothelioma Attorneys Mesothelioma Settlements Mesothelioma Claims

Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite

This laboratory study is looking for biomarkers to detect mesothelioma early in patients exposed to asbestos or vermiculite. Studying samples of body fluid and blood from patients who have been exposed to asbestos or vermiculite in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer.

  • Start Date: January 2007
  • Primary Completion Date:
  • Completion Date:
  • Last Updated Date: May 22, 2009

Disease Characteristics

  • Exposure to vermiculite or asbestos insulation
    • Symptomatic or nonsymptomatic exposure-related disease
  • Seen at a clinic in Libby, Montana (CARD Clinic) or Michigan (COEM)

Patient Characteristics

  • Not specified

Prior Concurrent Therapy

  • Not specified

Please refer to this study by its ClinicalTrials.gov identifier: NCT00897247.

Information on How You Can Participate In This Clinical Trial

Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201
313-576-9363

Sinai-Grace Hospital
Detroit, Michigan 48235
Contact: Naimei Tang 313-966-3300

Find More Information on